| Keywords |
Page Numbers |
| Adipokines |
119 |
| Age |
112 |
| Anesthesia |
239 |
| Antioxidant treatment |
133 |
| Assisted conception |
147 |
| Assisted reproductive techniques |
203 |
| Asymptomatic patient |
232 |
| Attachment |
192, 215 |
| B-hCG resolution |
198 |
| BMI |
112 |
| Behavior |
215 |
| Calcium channel blocker |
165 |
| Catheter ablation |
236 |
| Cesarean scar pregnancy |
198 |
| Cesarean section |
169, 215 |
| Checklist |
227 |
| Chemotherapy resistance |
153 |
| Childbirth |
209 |
| Clinical trial |
184 |
| ECT |
239 |
| Ectopic pregnancy |
198 |
| Education |
209 |
| Estrogen |
119 |
| Fear |
209 |
| Fecal incontinence |
125 |
| Fertility |
203 |
| First-generation |
133 |
| Foeniculum vulgare |
203 |
| GTN |
153 |
| Ghrelin |
119 |
| GnRH antagonist |
165 |
| Gonadotropin-releasing hormone agonist (GnRH) agonist |
165 |
| HPV |
232 |
| Hamadan |
221 |
| Hygienic habits |
158 |
| Hyperglycosylated human chorionic gonadotropin |
142 |
| Hysterectomy |
169 |
| Hysteroscopy |
198 |
| In vitro fertilization |
147 |
| Insulin resistance |
184 |
| Intermediate risk |
153 |
| Intrauterine growth retardation |
221 |
| Intrauterine insemination |
165 |
| Iran |
165 |
| LH surge |
165 |
| Lipid profile |
184 |
| Maternal-postnatal attachment scale |
192 |
| Metronidazole |
174 |
| Mice |
133 |
| Model of endometriosis |
133 |
| Natural menopause |
112 |
| Neurodevelopmental care |
192 |
| Nimodipine |
165 |
| Ovarian failure |
203 |
| Ovarian stimulation |
147 |
| PCR |
232 |
| POSEIDON criteria |
147 |
| Pain |
227 |
| Pain control |
227 |
| Pap smear |
232 |
| Peer group |
209 |
| Pelvic floor muscle exercise |
125 |
| Pelvic organ prolapse |
125 |
| Physical activity |
112 |
| Physiologic delivery |
215 |
| Physiotherapy |
125 |
| Phytotherapy |
203 |
| Placenta accreta |
142 |
| Placenta previa/accrete |
169 |
| Polycystic ovary syndrome |
184 |
| Poor ovarian response |
147 |
| Postmenopausal obesity |
119 |
| Prangos ferulacea |
174 |
| Prediction |
142 |
| Pregnancy |
158, 236, 239, 221 |
| Preterm infant |
192 |
| Prevalence |
232 |
| Psyllium |
184 |
| Reliability |
227 |
| Rural |
112 |
| Satiation |
119 |
| Sexual habits |
158 |
| Smoking |
112 |
| Third trimester |
169, 239 |
| Treatment |
174 |
| Trichomonas vaginalis |
174 |
| Urban |
112 |
| Urinary incontinence |
125 |
| Urinary tract infection |
158 |
| Validity |
227 |
| Ventricular tachycardia |
236 |
| Vitamin D |
221 |
|
|